What are the economic implications of the study on cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease? Recent clinical trials found that high-dose statin therapy, compared with conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with acute coronary syndromes (ACS) and stable coronary artery disease (CAD). What does this mean for the business of medicine? Have we established what one day of life is worth, and how do we know when to pay the price?
The Cost of High-Dose Statins
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
What are the economic implications of the study on cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease? Recent clinical trials found that high-dose statin therapy, compared with conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with acute coronary syndromes (ACS) and stable coronary artery disease (CAD). What does this mean for the business of medicine? Have we established what one day of life is worth, and how do we know when to pay the price?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Medical Industry Feature
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
<p>Digital Therapeutics Clinical Trials: From Design to Data Interpretation </p>
Medical Industry Feature
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
<p>Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology</p>
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
CME/CE Broadcast Replay
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
1.00 credits
<p>Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease</p>
CME/CE
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
0.50 credits
<p>IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?